| Vera French Community Mental Health Center | |
|
1441 W Central Park Ave Davenport IA 52804-1707 | |
| (563) 383-1900 | |
| (563) 884-4638 |
| Full Name | Vera French Community Mental Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 1441 W Central Park Ave, Davenport, Iowa |
| Authorized Official Name and Position | Anne P. Armknecht (CEO) |
| Authorized Official Contact | 5638886245 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Vera French Community Mental Health Center 1441 W Central Park Ave Davenport IA 52804-1707 Ph: (563) 383-1900 | Vera French Community Mental Health Center 1441 W Central Park Ave Davenport IA 52804-1707 Ph: (563) 383-1900 |
| NPI Number | 1245291129 |
|---|---|
| Provider Enumeration Date | 03/30/2006 |
| Last Update Date | 06/20/2018 |
| Medicare PECOS PAC ID | 6103715214 |
|---|---|
| Medicare Enrollment ID | O20040315000814 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245291129 | NPI | - | NPPES |
| 0074526 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (Iowa) | Secondary |
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | William M Nissen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225097843 PECOS PAC ID: 1951368885 Enrollment ID: I20041213000678 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | John F Stecker |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1821082850 PECOS PAC ID: 6608815444 Enrollment ID: I20050429000944 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Genevieve B Nelson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437238110 PECOS PAC ID: 9335170844 Enrollment ID: I20050824000947 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Dieter Boxmann |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023178548 PECOS PAC ID: 5092733428 Enrollment ID: I20070917000040 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Joyce Leann Morrison |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326156415 PECOS PAC ID: 7517044217 Enrollment ID: I20080404000579 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Jill Asbury |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1861532699 PECOS PAC ID: 4082783253 Enrollment ID: I20080514000863 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Rhonda L Callison |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1851434930 PECOS PAC ID: 2466521471 Enrollment ID: I20080516000428 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Chris M Pries |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205897337 PECOS PAC ID: 9032288055 Enrollment ID: I20080516000506 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | James R Bolton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1053452243 PECOS PAC ID: 0547331852 Enrollment ID: I20080613000315 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Taryn J Hancock |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1992846448 PECOS PAC ID: 7810046869 Enrollment ID: I20090521000168 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Susan L Armstrong |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1295868362 PECOS PAC ID: 4284759721 Enrollment ID: I20100922000450 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Rhonda K Scheffert |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1174727168 PECOS PAC ID: 3375623531 Enrollment ID: I20110301001111 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Laura M Hill |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1346393246 PECOS PAC ID: 8224216213 Enrollment ID: I20110622000016 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Concessa L Stecker |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1649385246 PECOS PAC ID: 6305915208 Enrollment ID: I20120425000494 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Jillyn M Kaufman |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528225158 PECOS PAC ID: 9537315163 Enrollment ID: I20120814000042 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Angela M Snyder |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1215288659 PECOS PAC ID: 1557509981 Enrollment ID: I20130524000343 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Anne C Gentil Archer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356774798 PECOS PAC ID: 7810124849 Enrollment ID: I20131218000658 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Marcin T Mika |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669734315 PECOS PAC ID: 9436371598 Enrollment ID: I20141105002517 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Denise A Beenk |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1669730602 PECOS PAC ID: 8325260276 Enrollment ID: I20141110002255 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Amy M Mccormick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275874273 PECOS PAC ID: 3971825902 Enrollment ID: I20141203000089 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Michael J Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104175405 PECOS PAC ID: 3779735683 Enrollment ID: I20150504002270 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Henry F Emerle |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336450790 PECOS PAC ID: 2365767373 Enrollment ID: I20150724011719 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Jennifer R Griffith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093180440 PECOS PAC ID: 4082900410 Enrollment ID: I20160909001994 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Tammi A White |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164771630 PECOS PAC ID: 3779733035 Enrollment ID: I20161103001527 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Susan L Kivisto |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477052405 PECOS PAC ID: 2668733189 Enrollment ID: I20180226001368 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Ty B Wakefield |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386005338 PECOS PAC ID: 9931461209 Enrollment ID: I20180326002122 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Ashley A Rosas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891272373 PECOS PAC ID: 3375894801 Enrollment ID: I20180924000750 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Shannon Jans |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053845677 PECOS PAC ID: 2860761822 Enrollment ID: I20190711000515 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Seema Antony |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457914657 PECOS PAC ID: 8123353026 Enrollment ID: I20190715003147 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Carol A Chukwuka |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174176093 PECOS PAC ID: 8729310255 Enrollment ID: I20191101000263 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Julie A Zogg |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1225557846 PECOS PAC ID: 0244639581 Enrollment ID: I20210519000512 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Kathleen J Mcguire |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1588193643 PECOS PAC ID: 0042588535 Enrollment ID: I20210812000337 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Julia C Sass |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003539784 PECOS PAC ID: 1557737434 Enrollment ID: I20221018000857 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Rose L Almquist |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1740641034 PECOS PAC ID: 8820468432 Enrollment ID: I20221222001878 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Dina M Lentz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205571155 PECOS PAC ID: 9234500356 Enrollment ID: I20230126002976 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Jamie J Haney |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1215573969 PECOS PAC ID: 3274907340 Enrollment ID: I20230314000534 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Gloria M Guillen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659901106 PECOS PAC ID: 8729418850 Enrollment ID: I20230814003568 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Roy E Henry |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306559786 PECOS PAC ID: 9638523079 Enrollment ID: I20231003003597 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Michelle L Lacouture |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508507237 PECOS PAC ID: 6002261690 Enrollment ID: I20231017003778 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | James Parcel |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1639212483 PECOS PAC ID: 6709236540 Enrollment ID: I20231220001765 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Jan Dumond |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1689136335 PECOS PAC ID: 3173973922 Enrollment ID: I20231220002153 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Kimberly Rude |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1508443821 PECOS PAC ID: 7810347531 Enrollment ID: I20231221000848 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Jay G Newell |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1831573138 PECOS PAC ID: 1153771423 Enrollment ID: I20231228002420 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Erin M Taylor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316568132 PECOS PAC ID: 4880041698 Enrollment ID: I20240104000998 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Grant Zimmerman |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1902264336 PECOS PAC ID: 1951752880 Enrollment ID: I20240104003963 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Heidi Harris-thomas |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1285043398 PECOS PAC ID: 0941653984 Enrollment ID: I20240126000206 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Lalaura L Logan-thomas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598438095 PECOS PAC ID: 2163875519 Enrollment ID: I20240201001421 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Hector A Meneses |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1669918389 PECOS PAC ID: 9537502570 Enrollment ID: I20240207001561 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
| Provider Name | Louise M Speer |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1710464292 PECOS PAC ID: 2769827757 Enrollment ID: I20240229001832 |
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
News Archive
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.
The follow-up results of a major study into babies born extremely prematurely have revealed that a high number of these children have a disability, although the levels of severity vary widely.
› Verified 8 days ago
Courageous Aim Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2805 Eastern Ave Ste D, Davenport, IA 52803 Phone: 563-505-0141 | |
Vera French Community Mental Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1441 W Central Park Ave, Davenport, IA 52804 Phone: 563-383-1900 Fax: 563-328-5690 | |
Hope For Tomorrow Therapy Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1140 E Kimberly Rd Ste 110, Davenport, IA 52807 Phone: 563-200-3154 Fax: 833-228-5356 | |
Ciaccio Medical, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1401 W Central Park Ave, Davenport, IA 52804 Phone: 309-236-8075 | |
The Robert Young Center For Community Mental Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12160 S Utah Ave, Davenport, IA 52804 Phone: 563-326-1150 | |
Revolution Counseling Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 601 Brady St Ste 204, Davenport, IA 52803 Phone: 309-781-4053 Fax: 309-792-2440 | |
Bhg Lxxxvi, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3811 North Harrison Street, Obot Room #100, Davenport, IA 52806 Phone: 563-388-8000 Fax: 563-388-8002 |